Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study.

Gebhardt, S; Theisen, F M; Haberhausen, M; Heinzel-Gutenbrunner, M; Wehmeier, P M; Krieg, J-C; Kühnau, W; Schmidtke, J; Remschmidt, H; Hebebrand, J

Gebhardt, S; Theisen, F M; Haberhausen, M; Heinzel-Gutenbrunner, M; Wehmeier, P M; Krieg, J-C; Kühnau, W; Schmidtke, J; Remschmidt, H; Hebebrand, J.

Affiliation

Gebhardt S; Clinical Research Group, Department of Child and Adolescent Psychiatry, University of Marburg, Germany. Stefan.Gebhardt@staff.uni-marburg.de

J Clin Pharm Ther ; 35(2): 207-11, 2010 Apr.

Article in En | MEDLINE | ID: mdl-20456740

Subject(s)

Antipsychotic Agents/adverse effects; Benzodiazepines/adverse effects; Risperidone/adverse effects; Weight Gain/drug effects; Adolescent; Adult; Body Mass Index; Body Weight/drug effects; Body Weight/genetics; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Olanzapine; Retrospective Studies; Siblings; Twins, Monozygotic; Weight Gain/genetics; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antipsychotic Agents / Benzodiazepines / Weight Gain / Risperidone Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google